EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:8736 - (R)-(+)-propranolol
| Formula | C16H21NO2 |
| Net Charge | 0 |
| Average Mass | 259.349 |
| Monoisotopic Mass | 259.15723 |
| SMILES | CC(C)NC[C@@H](O)COc1cccc2ccccc12 |
| InChI | InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3/t14-/m1/s1 |
| InChIKey | AQHHHDLHHXJYJD-CQSZACIVSA-N |
| Roles Classification |
|---|
| Chemical Roles: | environmental contaminant Any minor or unwanted substance introduced into the environment that can have undesired effects. Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | xenobiotic A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. human blood serum metabolite Any metabolite (endogenous or exogenous) found in human blood serum samples. |
| Applications: | cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. anti-asthmatic agent Any compound that has anti-asthmatic effects. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. hypoglycemic agent A drug which lowers the blood glucose level. renoprotective agent Any compound that is able to prevent damage to the kidneys. vasodilator agent A drug used to cause dilation of the blood vessels. hyperglycemic agent A drug which increases the blood glucose level. hepatoprotective agent Any compound that is able to prevent damage to the liver. vulnerary A drug used in treating and healing of wounds. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. nootropic agent Any compound that improves mental functions such as cognition, memory, intelligence, motivation, attention, and concentration. bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. vasoconstrictor agent Drug used to cause constriction of the blood vessels. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (R)-(+)-propranolol (CHEBI:8736) is a propranolol (CHEBI:8499) |
| Incoming Relation(s) |
| dexpropranolol hydrochloride (CHEBI:51161) has part (R)-(+)-propranolol (CHEBI:8736) |
| IUPAC Name |
|---|
| (2R)-3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol |
| INNs | Source |
|---|---|
| dexpropranolol | WHO MedNet |
| dexpropranolol | ChEBI |
| dexpropranololum | WHO MedNet |
| Synonyms | Source |
|---|---|
| (+)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol | ChemIDplus |
| 2R-Propranolol | ChemIDplus |
| Dexpropranolol | KEGG COMPOUND |
| Dextropropranolol | ChemIDplus |
| D-Propranolol | ChemIDplus |
| (+)-Propranolol | ChemIDplus |